Dentists in Hawley, PA Accepting Medicare
6 Dentists found. Showing 1 - 6
 Dr. John Evanish Iii, D.D.S Dentist - General Practice Medicare: Medicare Enrolled Practice Location: Hc 6 Box 6924, Route 6, Hawley, PA 18428 Phone: 570-226-8800 Fax: 570-226-4939 |
Dr. Richard Allen Hartland Ii, DMD Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: Hc 6 Box 6924, Hawley, PA 18428 Phone: 570-226-8800 |
Dr. John A Ridd, DMD Dentist Medicare: Medicare Enrolled Practice Location: 219 Hudson St, Hawley, PA 18428 Phone: 570-226-1919 Fax: 570-226-7499 |
Thomas Michael Yatsonsky, DMD Dentist - General Practice Medicare: Medicare Enrolled Practice Location: Rural Route 1 Box 476, Hawley, PA 18428 Phone: 570-685-7170 Fax: 570-685-7170 |
Niranjan Desai, DDS Dentist Medicare: Medicare Enrolled Practice Location: 2537 Route 6, Hawley, PA 18428 Phone: 570-226-8800 Fax: 570-226-3511 |
 Dr. May Eng-barrett, DDS Dentist - Orthodontics and Dentofacial Orthopedics Medicare: Not Enrolled in Medicare Practice Location: 212 Main Ave, Hawley, PA 18428 Phone: 570-226-2242 Fax: 570-226-2286 |
News Archive
AAN publishes new guideline on vaccinations for people with multiple sclerosis
Can a person with multiple sclerosis get regular vaccines? According to a new guideline, the answer is yes. The guideline, developed by the American Academy of Neurology, recommends that people with MS receive recommended vaccinations, including yearly flu shots.
New vaccine strategy to advance solutions for tuberculosis
Against a backdrop of growing concern about the impact of tuberculosis on children, top scientific experts today published a global plan of action for developing the vaccines that are seen as critical to eliminating the disease. Published today in a special issue of the journal, Tuberculosis , the strategic blueprint for the TB vaccine field, represents consensus reached by the TB vaccine community.
FDA approves Axiron topical solution CIII for testosterone replacement therapy in men
Acrux , a drug delivery company that develops and commercializes patented pharmaceutical products for global markets, and Eli Lilly Company today announced that the United States Food and Drug Administration (FDA) has approved the Axiron® topical solution CIII for testosterone replacement therapy in men. Axiron is the first testosterone topical solution approved for application via an underarm applicator.
Keele University researchers awarded grant to develop new treatment for musculoskeletal problems
Researchers at Keele University in the UK have been awarded a £1.93 million National Institute of Health Research (NIHR) Programme Grant for a new five year programme of research to develop a new treatment model for people with musculoskeletal problems in primary care, in which treatment will be tailored to patients' risk of persistent pain and disability.
› Verified 9 days ago